Cancer Research Breakthroughs Archives - Page 5 of 5 - NFCR

Cancer Research Breakthroughs

NFCR’s Genomics Newsroom: Using Molecular Imaging to Guide Cancer Therapy

Molecular imaging combines conventional anatomic imaging with genomic testing and enables doctors to literally see cancer at its molecular or genetic level....

Read more

New Treatment for Glioblastoma Multiforme Developed by NFCR Scientists

Dr. Web Cavenee and Dr. Paul B. Fisher discover a new pharmacological agent to treat glioblastoma multiforme (GBM), the deadliest brain cancer....

Read more

NFCR’s Genomics Newsroom: Bladder Cancer Could Be Treated the Same Way as Breast Cancer

Researchers from UNC, Chapel Hill found a subtype of bladder cancer has the same molecular signatures as a subset of breast cancer....

Read more

NFCR’s Genomics Newsroom: New Method to Detect Biomarkers

A method called MishCTC is being developed that will detect a molecular biomarker that is inside tumor cells but can’t be detected in normal blood cells....

Read more

NFCR’s Genomics Newsroom: Discovery of New Lung Cancer Mutation

The U.S. FDA approved the first and only drug to treat people with advanced non-small cell lung cancer (NSCLC) whose tumors express the ROS1+ mutation....

Read more

Research by NFCR Scientists Reveals New Insights into Treatment Resistance of Metastatic Breast Cancer

Oscillating expression of a key cancer gene may impact treatment approaches for patients NFCR-supported scientist Dr. Daniel Haber and his team at the Massachusetts General Hospital Cancer Center have identified a dynamic gene expression in metastatic breast cancer that may contribute to disease progression and resistance to treatment experienced by many…...

Read more

Genetic Sequencing and Diagnosis Sets a Guinness World Record

Can you imagine that a Guinness world record could be related to genetic sequencing and disease diagnosis? A world record for fastest genetic diagnosis was recently set by Dr. Stephen Kingsmore, president and CEO of Rady Children’s Institute for Genomic Medicine. Dr. Kingsmore is able to successfully diagnose critically ill…...

Read more

The First Successful Clinical Trial

Clinical Trial and translational medicine. Our CEO and son of the Founder of NFCR likes to talk history. Franklin C. Salisbury, Jr. notes the coincidence, perhaps, that the Salisbury name has long been associated with unheralded basic research that leads to major breakthroughs. Clinical trial and translational medicine –  bring…...

Read more

Breast Cancer Treatments in the News

New Treatments Could Shrink Breast Cancer in Just 11 Days For patients with HER2-positive breast cancer, a new combination therapy with two drugs could shrink or even eliminate their tumors in just 11 days. About 10% of breast cancers are HER2-positive, which is a subtype of breast cancer that is aggressive…...

Read more